Projects per year
Fingerprint
Dive into the research topics where Deborah Toppmeyer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 2 Finished
Research Output
-
5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial
Poppe, M. M., Yehia, Z. A., Baker, C., Goyal, S., Toppmeyer, D., Kirstein, L., Chen, C., Moore, D. F., Haffty, B. G. & Khan, A. J., Jul 15 2020, In : International Journal of Radiation Oncology Biology Physics. 107, 4, p. 694-700 7 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Clinical Outcomes in Early Breast Cancer with a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial
Sparano, J. A., Gray, R. J., Makower, D. F., Albain, K. S., Saphner, T. J., Badve, S. S., Wagner, L. I., Kaklamani, V. G., Keane, M. M., Gomez, H. L., Reddy, P. S., Goggins, T. F., Mayer, I. A., Toppmeyer, D. L., Brufsky, A. M., Goetz, M. P., Berenberg, J. L., Mahalcioiu, C., Desbiens, C., Hayes, D. F. & 9 others, , Mar 2020, In : JAMA Oncology. 6, 3, p. 367-374 8 p.Research output: Contribution to journal › Article › peer-review
Open Access19 Scopus citations -
Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)
Sharma, M. R., Mehrotra, S., Gray, E., Wu, K., Barry, W. T., Hudis, C., Winer, E. P., Lyss, A. P., Toppmeyer, D. L., Moreno-Aspitia, A., Lad, T. E., Velasco, M., Overmoyer, B., Rugo, H. S., Ratain, M. J. & Gobburu, J. V., Apr 1 2020, In : Journal of Clinical Pharmacology. 60, 4, p. 444-452 9 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
TBCRC 031: Randomized phase II study of neoadjuvant cisplatin versus doxorubicin-cyclophosphamide in germline BRCA carriers with her2-negative breast cancer (the inform trial)
Tung, N., Arun, B., Hacker, M. R., Hofstatter, E., Toppmeyer, D. L., Isakoff, S. J., Borges, V., Legare, R. D., Isaacs, C., Wolff, A. C., Marcom, P. K., Mayer, E. L., Lange, P. B., Goss, A. J., Jenkins, C., Krop, I. E., Winer, E. P., Schnitt, S. J. & Garber, J. E., Feb 2020, In : Journal of Clinical Oncology. 38, 14, p. 1539-1548 10 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Testing considerations for phosphatidylinositol-3-kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer
Toppmeyer, D. L. & Press, M. F., Sep 1 2020, In : Cancer Medicine. 9, 18, p. 6463-6472 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access